These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28867783)

  • 21. Mus musculus Papillomavirus 1: a New Frontier in Animal Models of Papillomavirus Pathogenesis.
    Spurgeon ME; Lambert PF
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32051276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Papillomavirus Infection and p16 Expression in Extragenital/Extraungual Bowen Disease in Immunocompromised Patients.
    Švajdler M; Mezencev R; Kašpírková J; Kacerovská D; Kazakov DV; Ondič O; Michal M
    Am J Dermatopathol; 2016 Oct; 38(10):751-7. PubMed ID: 26913849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rodent Papillomaviruses.
    Uberoi A; Lambert PF
    Viruses; 2017 Nov; 9(12):. PubMed ID: 29186900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel lineage-tracing mouse model for studying early MmuPV1 infections.
    Yilmaz V; Louca P; Potamiti L; Panayiotidis M; Strati K
    Elife; 2022 May; 11():. PubMed ID: 35533001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evasion of host immune defenses by human papillomavirus.
    Westrich JA; Warren CJ; Pyeon D
    Virus Res; 2017 Mar; 231():21-33. PubMed ID: 27890631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using
    King RE; Bilger A; Rademacher J; Ward-Shaw ET; Hu R; Lambert PF; Thibeault SL
    Viruses; 2022 May; 14(5):. PubMed ID: 35632742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stress keratin 17 enhances papillomavirus infection-induced disease by downregulating T cell recruitment.
    Wang W; Uberoi A; Spurgeon M; Gronski E; Majerciak V; Lobanov A; Hayes M; Loke A; Zheng ZM; Lambert PF
    PLoS Pathog; 2020 Jan; 16(1):e1008206. PubMed ID: 31968015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection.
    Nicholls PK; Klaunberg BA; Moore RA; Santos EB; Parry NR; Gough GW; Stanley MA
    Virology; 1999 Dec; 265(2):365-74. PubMed ID: 10600607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation.
    Meyers JM; Uberoi A; Grace M; Lambert PF; Munger K
    PLoS Pathog; 2017 Jan; 13(1):e1006171. PubMed ID: 28107544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stress keratin 17 and estrogen support viral persistence and modulate the immune environment during cervicovaginal murine papillomavirus infection.
    Wang W; Spurgeon ME; Pope A; McGregor S; Ward-Shaw E; Gronski E; Lambert PF
    Proc Natl Acad Sci U S A; 2023 Mar; 120(12):e2214225120. PubMed ID: 36917668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [PAPILLOMAVIRUS INFECTION: PRINCIPLE CHARACTERISTICS, CLINICAL MANIFESTATIONS, VACCINE PROPHYLAXIS].
    Lopukhov PD; Briko NI; Khaldin AA; Tsapkova NN; Lupashko OV
    Zh Mikrobiol Epidemiol Immunobiol; 2016; (1):71-8. PubMed ID: 27029121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mus musculus papillomavirus 1 is a key driver of skin cancer development upon immunosuppression.
    Dorfer S; Strasser K; Schröckenfuchs G; Bonelli M; Bauer W; Kittler H; Cataisson C; Fischer MB; Lichtenberger BM; Handisurya A
    Am J Transplant; 2021 Feb; 21(2):525-539. PubMed ID: 33063442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel pre-clinical murine model to study the life cycle and progression of cervical and anal papillomavirus infections.
    Cladel NM; Budgeon LR; Balogh KK; Cooper TK; Hu J; Christensen ND
    PLoS One; 2015; 10(3):e0120128. PubMed ID: 25803616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryo EM Analysis Reveals Inherent Flexibility of Authentic Murine Papillomavirus Capsids.
    Hartmann SR; Goetschius DJ; Hu J; Graff JJ; Bator CM; Christensen ND; Hafenstein SL
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
    Bhat P; Mattarollo SR; Gosmann C; Frazer IH; Leggatt GR
    Immunol Rev; 2011 Jan; 239(1):85-98. PubMed ID: 21198666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal models of papillomavirus pathogenesis.
    Campo MS
    Virus Res; 2002 Nov; 89(2):249-61. PubMed ID: 12445664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Defensive Mechanisms against Human Papillomavirus Infection.
    Moerman-Herzog A; Nakagawa M
    Clin Vaccine Immunol; 2015 Aug; 22(8):850-7. PubMed ID: 26063238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse papillomavirus type 1 (MmuPV1) DNA is frequently integrated in benign tumors by microhomology-mediated end-joining.
    Yu L; Majerciak V; Xue XY; Uberoi A; Lobanov A; Chen X; Cam M; Hughes SH; Lambert PF; Zheng ZM
    PLoS Pathog; 2021 Aug; 17(8):e1009812. PubMed ID: 34343212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulator of interferon genes (STING): A "new chapter" in virus-associated cancer research. Lessons from wild-derived mouse models of innate immunity.
    Poltorak A; Kurmyshkina O; Volkova T
    Cytokine Growth Factor Rev; 2016 Jun; 29():83-91. PubMed ID: 26980676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix.
    Ragonnaud E; Andersson AC; Mariya S; Pedersen AG; Burk RD; Folgori A; Colloca S; Cortese R; Nicosia A; Pamungkas J; Iskandriati D; Holst PJ
    J Immunother; 2017; 40(2):51-61. PubMed ID: 28166180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.